- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
Patent holdings for IPC class A61K 31/167
Total number of patents in this class: 4435
10-year publication summary
396
|
424
|
361
|
409
|
406
|
456
|
405
|
367
|
353
|
162
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Chiesi Farmaceutici S.p.A. | 950 |
63 |
The Regents of the University of California | 19803 |
39 |
The General Hospital Corporation | 4701 |
36 |
TARIS Biomedical LLC | 133 |
30 |
Board of Regents, The University of Texas System | 5745 |
26 |
The Procter & Gamble Company | 22020 |
24 |
Centre National de La Recherche Scientifique | 10311 |
23 |
Aeromics, Inc. | 28 |
22 |
Massachusetts Institute of Technology | 10002 |
21 |
The Johns Hopkins University | 5637 |
20 |
Cmpd Licensing, LLC | 77 |
20 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
19 |
University of Tennessee Research Foundation | 759 |
19 |
Allergan Industrie SAS | 83 |
18 |
The Trustees of Columbia University in the City of New York | 3558 |
17 |
Ohio State Innovation Foundation | 2098 |
17 |
Locl Pharma, Inc. | 19 |
16 |
Kenvue Brands LLC | 751 |
16 |
Achillion Pharmaceuticals, Inc. | 164 |
15 |
First Wave bio, Inc. | 26 |
15 |
Other owners | 3959 |